BROOKE HALL: Open Payments
NPI 1730665597 · CLAY CITY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 37 payments from 10 companies in 2025. Trend: 2023 $458 · 2024 $844 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $179 |
| GlaxoSmithKline, LLC. | 6 | $93 |
| ABBVIE INC. | 5 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Lilly USA, LLC | 3 | $52 |
| Amgen Inc. | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Exact Sciences Corporation | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
Products named: TRELEGY ELLIPTA, Rybelsus, Kerendia, MOUNJARO, Wegovy, Cologuard Collection Kit, LEQVIO, FARXIGA.
Industry payments across IN — which companies pay providers there.
